CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Neutral
AI Analysis

Summary

Nektar Therapeutics announced inducement stock option grants totaling 11,900 shares to employees on May 20, 2026, in compliance with Nasdaq listing rule 5635(c)(4).

Importance:1/10
Sentiment:
0.00
Stock OptionsInducement GrantsCorporate GovernanceNasdaq Compliance
Related Companies

Read the original article

Published by PR Newswire Biotech on June 3, 2026 8:15 PM

Read Original